Key result
Weight loss ≥10% linked to ~6-fold higher arrhythmia-free survival, while weight fluctuation increases recurrence.
Why the study?
Weight loss reduces the burden of atrial fibrillation, but whether this effect is sustained, dose-dependent, or influenced by weight fluctuation was unknown.
Does goal-directed weight management reduce AF burden and improve arrhythmia-free survival in obese patients with atrial fibrillation?
Cohort (n=355)
Does goal-directed weight management reduce AF burden and improve arrhythmia-free survival in obese patients with atrial fibrillation?
Sustained weight loss of ≥10% significantly improves arrhythmia-free survival and reduces AF burden in obese patients with atrial fibrillation.
Answers are grounded in this paper and cite their sources.
Should not yet change practice in obese AF; leaves open causal effects of sustained weight loss on recurrence.
BACKGROUND: Obesity and atrial fibrillation (AF) frequently coexist. Weight loss reduces the burden of AF, but whether this is sustained, has a dose effect, or is influenced by weight fluctuation is unknown. OBJECTIVES: This study sought to evaluate the long-term impact of weight loss and weight fluctuation on rhythm control in obese individuals with AF. METHODS: Of 1,415 consecutive patients with AF, 825 had a body mass index ≥ 27 kg/m(2) and were offered weight management. After screening for exclusion criteria, 355 were included in this analysis. Weight loss was categorized as group 1 (≥ 10%), group 2 (3% to 9%), and group 3 (<3%). Weight trend and/or fluctuation was determined by yearly follow-up. We determined the impact on the AF severity scale and 7-day ambulatory monitoring. RESULTS: There were no differences in baseline characteristics or follow-up among the groups. AF burden and symptom severity decreased more in group 1 compared with groups 2 and 3 (p < 0.001 for all). Arrhythmia-free survival with and without rhythm control strategies was greatest in group 1 compared with groups 2 and 3 (p < 0.001 for both). In multivariate analyses, weight loss and weight fluctuation were independent predictors of outcomes (p < 0.001 for both). Weight loss ≥ 10% resulted in a 6-fold (95% confidence interval: 3.4 to 10.3; p < 0.001) greater probability of arrhythmia-free survival compared with the other 2 groups. Weight fluctuation >5% partially offset this benefit, with a 2-fold (95% confidence interval: 1.0 to 4.3; p = 0.02) increased risk of arrhythmia recurrence. CONCLUSIONS: Long-term sustained weight loss is associated with significant reduction of AF burden and maintenance of sinus rhythm. (Long-Term Effect of Goal directed weight management on Atrial Fibrillation Cohort: A 5 Year follow-up study [LEGACY Study]; ACTRN12614001123639).
No takes yet. Share an insight, caveat, or question.
Pathak et al. (2015) conducted a cohort in Atrial Fibrillation and Obesity (n=355). Weight loss (≥ 10%) vs. Weight loss 3% to 9% or <3% was evaluated on Arrhythmia-free survival (6-fold greater probability, 95% CI 3.4 to 10.3, p=<0.001). Weight loss ≥10% yielded a 6-fold greater probability of arrhythmia-free survival compared with lesser weight loss (95% CI 3.4-10.3; p<0.001), while weight fluctuation >5% increased recurrence risk.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: